KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Assets: 2018-2025

Historic Return on Assets for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Sep 2025 value amounting to 0.02%.

  • Amneal Pharmaceuticals' Return on Assets rose 6.00% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 6.00%. This contributed to the annual value of -0.02% for FY2024, which is 1.00% down from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Return on Assets of 0.02% as of Q3 2025, which was up 8.69% from 0.02% recorded in Q2 2025.
  • Amneal Pharmaceuticals' Return on Assets' 5-year high stood at 0.02% during Q3 2025, with a 5-year trough of -0.07% in Q1 2023.
  • For the 3-year period, Amneal Pharmaceuticals' Return on Assets averaged around -0.02%, with its median value being -0.01% (2023).
  • In the last 5 years, Amneal Pharmaceuticals' Return on Assets climbed by 8bps in 2021 and then dropped by 8bps in 2022.
  • Amneal Pharmaceuticals' Return on Assets (Quarterly) stood at 0.01% in 2021, then decreased by 7bps to -0.07% in 2022, then rose by 5bps to -0.01% in 2023, then dropped by 1bps to -0.02% in 2024, then climbed by 6bps to 0.02% in 2025.
  • Its Return on Assets stands at 0.02% for Q3 2025, versus 0.02% for Q2 2025 and 0.01% for Q1 2025.